Healthcare CEO Guide: Building a “Clean” Customer/Patient Mix That Buyers Prefer
Healthcare CEO Guide: Building a “Clean” Customer/Patient Mix That Buyers Prefer Key Takeaways What Buyers Mean by a “Clean” Mix in 2026 Predictability Beats Hype Buyers define “clean mix” as predictable collections and low reimbursement volatility, not just growth. Advisors map payer, referral, and employer concentration, then align the story to what buyers can underwrite. […]
Read More
Healthcare CEO Guide: Handling Accounts Receivable and Working Capital in Smaller Deals
Healthcare CEO Guide: Handling Accounts Receivable and Working Capital in Smaller Deals Key Takeaways Why A/R Becomes a Deal Term In smaller practice transactions, buyers aren’t only buying EBITDA—they’re buying the ability to convert revenue into cash. If collections are slow or A/R quality is unclear, buyers protect themselves with working-capital targets, holdbacks, or post-close […]
Read More
Reimbursement Risk From a CEO’s Seat: What M&A Advisors Flag Before Buyers Do
Reimbursement Risk From a CEO’s Seat: What M&A Advisors Flag Before Buyers Do Key Takeaways Understanding Reimbursement Risk in Healthcare M&A For CEOs navigating a potential sale or merger, reimbursement risk is more than just a number on a balance sheet—it’s a key driver of deal value and buyer confidence. In healthcare, reimbursement risk refers […]
Read More